hematology

Advertisement

Advertisement

Cincinnati's Akebia starts Phase 1b clinical trial for anemia drug

Advertisement

Cincinnati’s Akebia begins Phase I human study on anemia drug

Cincinnati’s Akebia Therapeutics names new CFO